Skip to main content
Top
Published in: Malaria Journal 1/2016

Open Access 01-12-2016 | Research

Genotyping of Plasmodium vivax by minisatellite marker and its application in differentiating relapse and new infection

Authors: Ram Das, Ramesh C. Dhiman, Deepali Savargaonkar, Anupkumar R. Anvikar, Neena Valecha

Published in: Malaria Journal | Issue 1/2016

Login to get access

Abstract

Background

Plasmodium vivax malaria is a major public health problem in India. Control of vivax malaria is challenging due to various factors including relapse which increase the burden significantly. There is no well studied marker to differentiate relapse from reinfection. This creates hindrance in search for anti-relapse medicines. The genomic study of minisatellite can help in characterization of relapse and new infection of vivax malaria.

Methods

Eighty-eight samples of P. vivax were collected from malaria clinic. All the 14 chromosomes of P. vivax were scanned for minisatellite marker by Tandem Repeat Finder software Version 4.07b. Minisatellite marker CH1T1M13779 from chromosome one was applied for genotyping in 88 samples of P. vivax including 2 recurrence cases.

Results

Whole genome of P. vivax was scanned and found to have one hundred minisatellite markers. CH1T1M13779 minisatellite marker from chromosome-1 was used for amplification in 88 samples of P. vivax. Of 66 amplified samples, 14 alleles were found with varied allele frequency. The base size of 280 (13.63 %) 320 bp (13.63 %) and 300 bp (16.66 %) showed the predominant allele in the P. vivax population. Genotyping of two paired samples (day 0 and day relapse) could demonstrate the presence of relapse and reinfection.

Conclusion

The CH1T1M13779 can be potential minisatellite marker which can be used to differentiate between relapse and new infection of P. vivax strain.
Literature
1.
go back to reference WHO. Guidelines for the treatment of malaria, second edition. Geneva, World Health Organization, 2010. http://www.who.int/malaria/publication/atos/978941547925/enindex.html. WHO. Guidelines for the treatment of malaria, second edition. Geneva, World Health Organization, 2010. http://​www.​who.​int/​malaria/​publication/​atos/​978941547925/​enindex.​html.​
2.
go back to reference Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present and future. Lancet Infect Dis. 2004;4:327–36.PubMedCentralCrossRefPubMed Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present and future. Lancet Infect Dis. 2004;4:327–36.PubMedCentralCrossRefPubMed
3.
go back to reference Adak T, Valecha N, Sharma VP. Plasmodium vivax polymorphism in a clinical drug trial. Clin Diagn Lab Immunol. 2001;8:891–4.PubMedCentralPubMed Adak T, Valecha N, Sharma VP. Plasmodium vivax polymorphism in a clinical drug trial. Clin Diagn Lab Immunol. 2001;8:891–4.PubMedCentralPubMed
4.
go back to reference Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007;195:927–33.CrossRefPubMed Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007;195:927–33.CrossRefPubMed
6.
go back to reference Prajapati SK, Joshi M, Shalini S, Patarroyo MA, Suwanarusk R, Kumar A, et al. Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship. Malar J. 2011;10:374.PubMedCentralCrossRefPubMed Prajapati SK, Joshi M, Shalini S, Patarroyo MA, Suwanarusk R, Kumar A, et al. Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship. Malar J. 2011;10:374.PubMedCentralCrossRefPubMed
7.
go back to reference Zakeri S, Barjesteh H, Djadid ND. Merozoite surface protein-3alpha is a reliable marker for population genetic analysis of Plasmodium vivax. Malar J. 2006;5:53.PubMedCentralCrossRefPubMed Zakeri S, Barjesteh H, Djadid ND. Merozoite surface protein-3alpha is a reliable marker for population genetic analysis of Plasmodium vivax. Malar J. 2006;5:53.PubMedCentralCrossRefPubMed
8.
go back to reference Prajapati SK, Joshi H, Valecha N. Plasmodium vivax merozoite surface protein-3a: a high resolution marker for genetic diversity studies. J Vector Borne Dis. 2010;47:85–90.PubMed Prajapati SK, Joshi H, Valecha N. Plasmodium vivax merozoite surface protein-3a: a high resolution marker for genetic diversity studies. J Vector Borne Dis. 2010;47:85–90.PubMed
9.
go back to reference Imwong M, Pukrittayakamee S, Grüner AC, Rénia L, Letourneur F, Looareesuwan S, et al. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J. 2005;4:20.PubMedCentralCrossRefPubMed Imwong M, Pukrittayakamee S, Grüner AC, Rénia L, Letourneur F, Looareesuwan S, et al. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J. 2005;4:20.PubMedCentralCrossRefPubMed
10.
go back to reference Kim JR, Imwong M, Nandy A, Chotivanich K, Nontprasert A, Tonomsing N, et al. Genetic diversity of Plasmodium vivax in Kolkata. India. Malar J. 2006;5:71.CrossRefPubMed Kim JR, Imwong M, Nandy A, Chotivanich K, Nontprasert A, Tonomsing N, et al. Genetic diversity of Plasmodium vivax in Kolkata. India. Malar J. 2006;5:71.CrossRefPubMed
12.
go back to reference Imwong M, Pukrittakayamee S, Looareesuwan S, Poirriez J, Pasvol G, White NJ, et al. Plasmodium vivax: polymerase chain reaction amplification artifacts limit the suitability of pvgam1 as a genetic marker. Exp Parasitol. 2001;99:175–9.CrossRefPubMed Imwong M, Pukrittakayamee S, Looareesuwan S, Poirriez J, Pasvol G, White NJ, et al. Plasmodium vivax: polymerase chain reaction amplification artifacts limit the suitability of pvgam1 as a genetic marker. Exp Parasitol. 2001;99:175–9.CrossRefPubMed
13.
go back to reference Prajapati SK, Verma A, Adak T, Yadav RS, Kumar A, Eapen A, et al. Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent. Malar J. 2006;5:90.PubMedCentralCrossRefPubMed Prajapati SK, Verma A, Adak T, Yadav RS, Kumar A, Eapen A, et al. Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent. Malar J. 2006;5:90.PubMedCentralCrossRefPubMed
14.
go back to reference Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, Kho WG, Kaneoko A, et al. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc Natl Acad Sci USA. 2002;99:16348–53.PubMedCentralCrossRefPubMed Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, Kho WG, Kaneoko A, et al. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc Natl Acad Sci USA. 2002;99:16348–53.PubMedCentralCrossRefPubMed
15.
go back to reference Rayner JC, Huber CS, Feldman D, Ingravallo P, Galinski MR, Barnwell JW. Plasmodium vivax merozoite surface protein PvMSP-3 beta is radically polymorphic through mutation and large insertions and deletions. Infect Genet Evol. 2004;4:309–19.CrossRefPubMed Rayner JC, Huber CS, Feldman D, Ingravallo P, Galinski MR, Barnwell JW. Plasmodium vivax merozoite surface protein PvMSP-3 beta is radically polymorphic through mutation and large insertions and deletions. Infect Genet Evol. 2004;4:309–19.CrossRefPubMed
16.
go back to reference Yang Z, Miao J, Huang Y, Li X, Putaporntip C, Jongwutiwes S, et al. Genetic structures of geographically distinct Plasmodium vivax populations assessed by PCR/RFLP analysis of the merozoite surface protein 3beta gene. Acta Trop. 2006;100:205–12.PubMedCentralCrossRefPubMed Yang Z, Miao J, Huang Y, Li X, Putaporntip C, Jongwutiwes S, et al. Genetic structures of geographically distinct Plasmodium vivax populations assessed by PCR/RFLP analysis of the merozoite surface protein 3beta gene. Acta Trop. 2006;100:205–12.PubMedCentralCrossRefPubMed
17.
go back to reference Gomez A, Suarez CF, Martinez P, Saravia C, Patarroyo MA. High polymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5). Parasitology. 2006;133:661–72.CrossRefPubMed Gomez A, Suarez CF, Martinez P, Saravia C, Patarroyo MA. High polymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5). Parasitology. 2006;133:661–72.CrossRefPubMed
18.
go back to reference Sousa TN, Ceravolo IP, Fernandes FCJ, Couto A, Carvalho LH, Brito CF. The pattern of major polymorphisms in the Duffy binding protein ligand domain among Plasmodium vivax isolates from the Brazilian Amazon area. Mol Biochem Parasitol. 2006;146:251–4.CrossRefPubMed Sousa TN, Ceravolo IP, Fernandes FCJ, Couto A, Carvalho LH, Brito CF. The pattern of major polymorphisms in the Duffy binding protein ligand domain among Plasmodium vivax isolates from the Brazilian Amazon area. Mol Biochem Parasitol. 2006;146:251–4.CrossRefPubMed
19.
go back to reference Han ET, Park JH, Shin EH, Choi MH, Oh MD, Chai JY. Apical membrane antigen-1 (AMA-1) gene sequences of re-emerging Plasmodium vivax in South Korea. Korean J Parasitol. 2002;40:157–62.PubMedCentralCrossRefPubMed Han ET, Park JH, Shin EH, Choi MH, Oh MD, Chai JY. Apical membrane antigen-1 (AMA-1) gene sequences of re-emerging Plasmodium vivax in South Korea. Korean J Parasitol. 2002;40:157–62.PubMedCentralCrossRefPubMed
21.
go back to reference McCollum AM, Valeria S, Salas CJ, Santolalla ML, Udhayakumar V, Escalante AA, et al. Genetic variation and recurrent parasitaemia in Peruvian Plasmodium vivax populations. Malar J. 2014;13:67.PubMedCentralCrossRefPubMed McCollum AM, Valeria S, Salas CJ, Santolalla ML, Udhayakumar V, Escalante AA, et al. Genetic variation and recurrent parasitaemia in Peruvian Plasmodium vivax populations. Malar J. 2014;13:67.PubMedCentralCrossRefPubMed
22.
go back to reference NVBDCP: National drug policy on malaria, Ministry of Health and Family Welfare/Directorate of National Vector Borne Disease Control Programme, Govt. of India. 2010. http://www.nvbdcp.gov.in. NVBDCP: National drug policy on malaria, Ministry of Health and Family Welfare/Directorate of National Vector Borne Disease Control Programme, Govt. of India. 2010. http://​www.​nvbdcp.​gov.​in.
24.
go back to reference Lin JT, Juliano JJ, Kharabora O, Sem R, Lin FC, Muth S, et al. Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapse. J Clin Microbiol. 2012;50:1449–51.PubMedCentralCrossRefPubMed Lin JT, Juliano JJ, Kharabora O, Sem R, Lin FC, Muth S, et al. Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapse. J Clin Microbiol. 2012;50:1449–51.PubMedCentralCrossRefPubMed
25.
go back to reference Andrianaranjaka V, Lin JT, Golden C, Juliano JJ, Randrianarivelojosia M. Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old manwith relapsing malaria in Antananarivo. Madagascar. Malar J. 2013;12:177.CrossRefPubMed Andrianaranjaka V, Lin JT, Golden C, Juliano JJ, Randrianarivelojosia M. Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old manwith relapsing malaria in Antananarivo. Madagascar. Malar J. 2013;12:177.CrossRefPubMed
26.
go back to reference Givens MB, Lin JT, Lon C, Gosi P, Char MC, Lanter CA, et al. Development of a capillary electrophoresis-cased heteroduplex tracking assay to measure in host genetic diversity of initial and recurrent Plasmodium vivax infections in Cambodia. J Clin Microbiol. 2014;52:298–301.PubMedCentralCrossRefPubMed Givens MB, Lin JT, Lon C, Gosi P, Char MC, Lanter CA, et al. Development of a capillary electrophoresis-cased heteroduplex tracking assay to measure in host genetic diversity of initial and recurrent Plasmodium vivax infections in Cambodia. J Clin Microbiol. 2014;52:298–301.PubMedCentralCrossRefPubMed
27.
go back to reference Lin JT, Hathaway NJ, Saunders DL, Lon C, Balasubramanian S, Kharabora O, et al. Using amplicon deep sequencing to detect genetic signatures of Plasmodium vivax relapse. J Infect Dis. 2015;212:999–1008. doi:10.1093/infdis/jiv142.CrossRefPubMed Lin JT, Hathaway NJ, Saunders DL, Lon C, Balasubramanian S, Kharabora O, et al. Using amplicon deep sequencing to detect genetic signatures of Plasmodium vivax relapse. J Infect Dis. 2015;212:999–1008. doi:10.​1093/​infdis/​jiv142.CrossRefPubMed
28.
go back to reference Koepfli C, Mueller I, Marfurt J, Goroti M, Sie A, et al. Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials. J Infect Dis. 2009;199:1074–80.CrossRefPubMed Koepfli C, Mueller I, Marfurt J, Goroti M, Sie A, et al. Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials. J Infect Dis. 2009;199:1074–80.CrossRefPubMed
29.
go back to reference Cui L, Escalante AA, Imwong M, Snounou G. The genetic diversity of Plasmodium vivax populations. Trends Parasitol. 2003;19:220–6.CrossRefPubMed Cui L, Escalante AA, Imwong M, Snounou G. The genetic diversity of Plasmodium vivax populations. Trends Parasitol. 2003;19:220–6.CrossRefPubMed
Metadata
Title
Genotyping of Plasmodium vivax by minisatellite marker and its application in differentiating relapse and new infection
Authors
Ram Das
Ramesh C. Dhiman
Deepali Savargaonkar
Anupkumar R. Anvikar
Neena Valecha
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2016
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-016-1139-3

Other articles of this Issue 1/2016

Malaria Journal 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.